Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

MegaPro Biomedical Co., Ltd. (6827) Income Statement

MegaPro Biomedical Co., Ltd. Income Statement

Last quarter (Q2 2026), MegaPro Biomedical Co., Ltd.'s total revenue was NT$0.00, a decrease of 100.00% from the same quarter last year. In Q2, MegaPro Biomedical Co., Ltd.'s net income was NT$-49.69M. See MegaPro Biomedical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 0.00NT$ 14.00KNT$ 18.00KNT$ 0.00NT$ 0.00
NT$ 0.00NT$ -17.19MNT$ -16.60MNT$ -13.56MNT$ -7.54M
NT$ 119.59MNT$ 163.00MNT$ 123.89MNT$ 108.19MNT$ 93.44M
Depreciation and AmortizationNT$ 15.05MNT$ 17.21MNT$ 16.62MNT$ 13.56MNT$ 7.54M
NT$ -103.91MNT$ -146.38MNT$ -110.34MNT$ -97.36MNT$ -81.61M
NT$ -119.59MNT$ -180.19MNT$ -140.49MNT$ -121.75MNT$ -100.97M
NT$ 484.00KNT$ 16.15MNT$ 12.94MNT$ 10.46MNT$ 11.82M
NT$ -119.10MNT$ -164.04MNT$ -127.55MNT$ -111.29MNT$ -89.15M
NT$ -119.10MNT$ -164.04MNT$ -127.55MNT$ -111.72MNT$ -89.15M
Per Share Metrics
Basic EPSNT$ -1.77NT$ -2.68NT$ -2.46NT$ -2.02NT$ -1.65
Diluted EPSNT$ -1.77NT$ -2.68NT$ -2.30NT$ -2.02NT$ -1.65
Weighted Average Shares Outstanding67.31M61.21M51.86M55.40M54.07M
Weighted Average Shares Outstanding (Diluted)67.31M61.21M51.86M55.40M54.07M

Currency in TWD

MegaPro Biomedical Co., Ltd. Earnings and Revenue History

-200M-100M0100M-1500000 %-1000000 %-500000 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin